BioCentury
ARTICLE | Emerging Company Profile

Entomed: Drugs from bugs

June 3, 2002 7:00 AM UTC

Insects may provide a rich source of novel peptide and small molecule chemistry, but they have been untapped because little has been known about their immune systems. Entomed SA is taking advantage of work done over the last 15 years to harness the insect immune system to fuel its lead discovery efforts.

"There are 2 million known insect species," CEO Mario Thomas told BioCentury. "That represents about 90% of all animal species and 61% of all living species, including plants and microorganisms."...